Indian drugmakers have played a crucial role in supplying generic and affordable drugs in the US US pharma companies have ...

LTR Pharma completes $25 million placement to support its Spontan ED nasal spray through FDA regulatory pathway and ...

leverage the therapeutic opportunity of this pathway; and critically address the huge unmet clinical need. Download the full event guide here. Discover how AI is transforming the pharma commercial ...

WEST CHESTER, PA — Pathways Neuro Pharma, Inc. has announced a strategic partnership with Dragonfly 44 Capital, a move set to ...

Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") a pharmaceutical technology ...

The $20 trillion consumer-driven economy in the United States is breaking structurally, in the grips of the Big Fear and unseen forces of compression. Americans are hoarding cash, slashing spending ...

SAN DIEGO--(BUSINESS WIRE)--Onchilles Pharma, a private biotech company pioneering pan-cancer therapeutics that leverage the ELANE pathway, today announced the presentation of new preclinical data ...

underscoring a pathway to support a future New Drug Application (NDA) submission for Mino-Lok. Citius Pharmaceuticals NewsMORE Related Stocks Indices Commodities Currencies Stocks ...

(RTTNews) - Shares of Citius Pharmaceuticals (CTXR ... the FDA's questions related to Mino-Lok's clinical trial data and a pathway to a future submission. The company said that the FDA provided ...